Features
- Proteins, such as Insulin and SARS-CoV-2 RBD, are selected to develop therapeutic candidates
- Fc region selected for species-specificity
- Saccharides enhance or suppress immune interaction
- Insulin mutations and c-peptide composition control insulin receptor activity
- Proprietary modifications reduce immunogenicity
- Linker moeity can be “tuned” for manufacturability